When I began working in medical research, I was shocked to find that no one in the medical industry has actually collected and compared all of the clinical outcomes data that has been published. With Big Data in Healthcare as such a major initiative, it was incomprehensible to me that the highest-value data–the data that is directly used to clear therapies, recommend them to the medical community, and assess their efficacy–were being managed in the following way:
- Physician completes study, and then spends up to a year writing it up and submitting it,
- Journal sits on the study for months, then publishes (in some cases), but without ensuring that it matches similar studies in the data it reports.
- Oh, by the way, the journal does not make the data available in a structured format!
- Then, if you want to see how that one study compares to related studies, you have to either find a recent, comprehensive, on-point meta-analysis (which is a very low chance in my experience), or comb the literature and extract the data by hand.
- That’s it.
This strikes me as mismanagement of data that are relevant to lifechanging healthcare decisions. Effectively, no one in the medical field has anything like what the financial industry has had for decades–the Bloomberg terminal, which presents comprehensive information on an updatable basis by pulling data from centralized repositories. If we can do it for stocks, we can do it for medical studies, and in fact that is what I am trying to do. I recently wrote an article on the topic for the Minneapolis-St Paul Business Journal, calling for the medical community to support a centralized, constantly-updated, data-centric platform to enable not only physicians but also insurers, policymakers, and even patients examine the actual scientific consensus, and the data that support it, in a single interface.
Read the full article at https://www.bizjournals.com/twincities/news/2019/12/27/there-is-no-bloomberg-for-medicine.html!